The ErbB Receptors and their Ligands in Cancer: An Overview
Journal:
Current Drug Targets
Volume:
6
Page:
243-257
Author(s):
N. Normanno, C. Bianco, L. Strizzi, M. Mancino, M. R. Maiello, A. De Luca, F. Caponigro and D. S. Salomon
Small Molecules with EGFR-TK Inhibitor Activity
Journal:
Current Drug Targets
Volume:
6
Page:
259-274
Author(s):
Joan Albanell and Pere Gascon
Antitumor Therapeutic Strategies Based on the Targeting of Epidermal Growth Factor-Induced Survival Pathways
Journal:
Current Drug Targets
Volume:
6
Page:
289-300
Author(s):
P. Tagliaferri, P. Tassone, S. Blotta, C. Viscomi, F. Grillone, A. Budillon, M. Caraglia and S. Venuta
Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Journal:
Current Drug Targets
Volume:
6
Page:
301-323
Author(s):
M. Caraglia, A. Budillon, P. Tagliaferri, M. Marra, A. Abbruzzese and F. Caponigro
Drugging Cell Cycle Kinases in Cancer Therapy
Journal:
Current Drug Targets
Volume:
6
Page:
325-335
Author(s):
S. Blagden and J. de Bono
Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase
Journal:
Current Drug Targets
Volume:
6
Page:
337-351
Author(s):
A. Budillon, F. Bruzzese, E. Di Gennaro and M. Caraglia
Recent Developments in the Chemical Biology of Epothilones
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1595-1613
Author(s):
Karl Heinz Altmann
Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1719-1733
Author(s):
N. M. Verrills and M. Kavallaris
Editorial [Hot Topic: Mini Hot Topic Title: Epigenetic Regulatory Mechanisms in Cancer, Development, and Evolution (Guest Editor: Douglas M. Ruden)]
Journal:
Current Genomics
Volume:
6
Page:
127-127
Author(s):
Douglas M. Ruden
The Epigenetics of Breast Carcinogenesis and Metastasis
Journal:
Current Genomics
Volume:
6
Page:
129-135
Author(s):
S. M.O. Phipps, W. K. Woodfin and T. O. Tollefsbol